| 5I9W: reference: Chemical proteomics and structural biology define EPHA2 inhibition by clinical kinase drugs., Heinzlmeir S, Kudlinzki D, Sreeramulu S, Klaeger S, Gande SL, Linhard V, Wilhelm M, Qiao H, Helm D, Ruprecht B, Saxena K, Medard G, Schwalbe H, Kuster B, ACS Chem Biol. 2016 Oct 21. PMID: 27768280 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).